China’s prominence in the global market for continuous glucose monitoring (CGM) systems is expected to grow at a considerable rate. The expansion of medical and healthcare industry in China has fuelled the country’s consumption rate for CGM devices and equipment. Growing urbanisation has witnessed increase in establishment of diagnostics centres in populous cities, providing healthcare facilities and treatments for several ailments. Diabetes remains to a common and prevalent health implication, which has surged the revenue share of China in global continuous glucose monitoring systems market. Future Market Insights (FMI) has compiled a report on the dominance of China is Asia-Pacific CGM systems market and its value share in global market.
According to FMI’s report, the brimming population in China serves the cause for rising incidences of health irregularities. Scant agricultural produce has been facing challenges while meeting the piling consumption demands, resulting to occurrence of malnutrition. Lesser availability of nutritional foods, increasing consumption of cheap and unhealthy products and exhaustive work routines have collectively triggered the occurrence of diabetic disorders among Chinese consumers. Increase concentration levels of polyunsaturated sugars in cheap and unhealthy food items has induced greater exposure towards risks of cholesterol-related disorders. Excessive work lifestyle in China demands better nutrition, which if rendered unmet can cause dietary disorders and rampantly increase saturated glucose levels in blood.
China’s value share in continuous glucose monitoring systems market is also influenced by the production potential of the region. Low labour costs and availability of industrial technologies are prompting global leaders in manufacturing of CGM systems to set up production plants in China, thereby fostering its global clout. FMI’s report estimates that by 2020, Asia-Pacific excluding Japan (APEJ) region is slated to expand at highest CAGR, with China’s revenue share being the foremost attributer.
More information on China’s revenue share in continuous glucose monitoring systems can be accessed by availing a free sample of FMI’s report at www.futuremarketinsights.com/reports/sample/rep-gb-694.
This post has been seen 111 times.